<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Dobson Drejer | Activity</title>
	<link>https://brycefoster.com/members/lungbrass3/activity/</link>
	<atom:link href="https://brycefoster.com/members/lungbrass3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Dobson Drejer.</description>
	<lastBuildDate>Tue, 28 Apr 2026 12:42:50 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5f838b25b234dfa6d4dffda2e081af09</guid>
				<title>Dobson Drejer posted an update: The Evolution of GLP-1 Drugs in Germany: A Comprehensive [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1544407/</link>
				<pubDate>Thu, 16 Apr 2026 15:40:39 +0000</pubDate>

									<content:encoded><![CDATA[<p>The Evolution of GLP-1 Drugs in Germany: A Comprehensive Guide to Treatment, Regulation, and Availability</p>
<p>Recently, the pharmaceutical landscape in Germany has undergone a considerable shift with the arrival and rapid adoption of GLP-1 receptor agonists (GLP-1 RAs). Initially developed to handle Type 2 diabetes, these medications&#8211; recognized&hellip;<span class="activity-read-more" id="activity-read-more-1544407"><a href="https://brycefoster.com/activity/p/1544407/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fef6d310b7ef02fa154a4c230422e965</guid>
				<title>Dobson Drejer became a registered member</title>
				<link>https://brycefoster.com/activity/p/1544392/</link>
				<pubDate>Thu, 16 Apr 2026 15:29:11 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>